Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-synuclein binding to rab3a in multiple system atrophy.

E Dalfó1, I Ferrer

  • 1Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, carrer Feixa Llarga sn, 08907 Hospitalet de Llobregat, Spain.

Neuroscience Letters
|April 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caenorhabditis elegans RAC1/ced-10 mutants as a new animal model to study very early stages of Parkinson's disease.

Progress in neurobiology·2024
Same author

Differential overexpression of SERPINA3 in human prion diseases.

Scientific reports·2017
Same author

Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome.

The British journal of dermatology·2017
Same author

Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.

Current Alzheimer research·2017
Same author

Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease.

Biochimica et biophysica acta. Biomembranes·2017
Same author

Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology.

Neuropathology and applied neurobiology·2017
Same journal

Dynorphinergic neuroadaptations in the islands of Calleja: implications for alcohol use disorder.

Neuroscience letters·2026
Same journal

Differential vulnerability of cochlear nuclei to Lmx1 deficiency: abnormal patterning and implications for auditory circuitry.

Neuroscience letters·2026
Same journal

Role of nNOS/sGC pathway in the insular cortex in control of cardiovascular, autonomic and corticosterone responses to restraint stress in rats.

Neuroscience letters·2026
Same journal

Jak1 inhibition reduces acute allodynia induced by specific upstream cytokines in rats: implications for the onset of Jak1 pain modulation.

Neuroscience letters·2026
Same journal

Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone - A comparative study.

Neuroscience letters·2026
Same journal

Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.

Neuroscience letters·2026
See all related articles

Abnormal alpha-synuclein binding to rab3a suggests impaired membrane and synaptic vesicle trafficking in multiple system atrophy (MSA) and Parkinson's disease. This interaction may be a key factor in disease pathogenesis.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Glial cytoplasmic inclusions (GCIs), composed of phosphorylated alpha-synuclein, are hallmarks of multiple system atrophy (MSA).
  • Widespread alpha-synuclein accumulation occurs in neurons and brain regions like the thalamus and cerebral cortex in MSA.

Purpose of the Study:

  • To investigate the interaction between alpha-synuclein and rab3a in the brains of patients with MSA and Parkinson's disease.
  • To determine if alpha-synuclein/rab3a binding is associated with disease-specific pathology and brain regions.

Main Methods:

  • Combined alpha-synuclein and rab3a immunoprecipitation assays were performed on brain tissue samples.
  • Analysis included cerebellum, pons, cerebral cortex, and substantia nigra from MSA, Parkinson's disease, and age-matched control cases.

Related Experiment Videos

Main Results:

  • Alpha-synuclein/rab3a binding was detected in the cerebellum and pons (with GCIs) and cerebral cortex (without GCIs) in MSA cases, but not in controls.
  • Similar abnormal binding was observed in MSA-C and MSA-P subtypes, and in the substantia nigra in Parkinson's disease.
  • No significant binding was found in the cerebral cortex in Parkinson's disease cases.

Conclusions:

  • The findings suggest abnormal interactions between alpha-synuclein and rab3a in diseased brains, indicating potential roles in MSA and Parkinson's disease pathogenesis.
  • Membrane and synaptic vesicle trafficking are identified as vulnerable targets in MSA due to the involvement of rab3a in these processes.